Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies

This publication has 21 references indexed in Scilit:

• Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
  Nature Medicine, 2014
• Liquid Biopsies: Genotyping Circulating Tumor DNA
  Journal of Clinical Oncology, 2014
• Detection of cancer cells in the cerebrospinal fluid: current methods and future directions
  Fluids and Barriers of the CNS, 2011
• Diagnostic Tools for Neoplastic Meningitis: Detecting Disease, Identifying Patient Risk, and Determining Benefit of Treatment
  Seminars in Oncology, 2009
• Detection of Mutant BRAF Alleles in the Plasma of Patients with Metastatic Melanoma
  The Journal of Molecular Diagnostics, 2007
• Detection of mutated BRAFV600E variant in circulating DNA of stage III–IV melanoma patients
  International Journal of Cancer, 2007
• The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses
  Clinical Cancer Research, 2007
• Molecular Detection of Metastatic Melanoma Cells in Cerebrospinal Fluid in Melanoma Patients
  Journal of Investigative Dermatology, 2001
• Detection of Tumor-derived DNA in Cerebrospinal Fluid
  Journal of Neuropathology & Experimental Neurology, 1994
• Alteration of blood-CSF barrier by tumor invasion into the meninges
  Journal of Neurosurgery, 1981